CITIC Securities, in its research report, asserts that artificial intelligence (AI) in healthcare is set to expedite the transformation of the pharmaceutical market, which is valued in the trillions of dollars. The report highlights that a pivotal shift in the underlying rationale of AI healthcare is anticipated in 2026. The primary catalyst for this transformation is the clarity regarding the entities responsible for funding AI healthcare initiatives and their enhanced financial capacity. Consequently, 2026 is poised to be a landmark year, marked by increased certainty in the commercialization of AI healthcare and a broadening of its commercial prospects. CITIC Securities advises stakeholders to concentrate on five strategic domains and their associated objectives: AI-driven pharmaceutical innovation, AI applications in primary healthcare settings, the circulation and trading of medical data, AI-assisted pathological diagnostics, AI healthcare models, and channels for expanding into the consumer (C) end market.